Cellectar Biosciences Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $4.45 on 03/04/24, while the lowest price during the same period was $1.30 on 04/11/23.
52-week price history of CLRB Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Cellectar Biosciences Inc’s current trading price is -16.40% away from its 52-week high, while its distance from the 52-week low is 186.15%. The stock’s price range for this period has remained between $1.30 and $4.45. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.63 million for the day, which was noticeably lower compared to the shares’ average daily volume of 1.84 million over the last three months.
Financial Performance and Market Capitalization
Cellectar Biosciences Inc (CLRB) has experienced a quarterly rise of 31.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 120.01M and boasts a workforce of 20 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.20, with a change in price of +1.64. Similarly, Cellectar Biosciences Inc recorded 1,289,598 in trading volume during the last 100 days, posting a change of +78.85%.
CLRB Stock Stochastic Average
As of today, the raw stochastic average of Cellectar Biosciences Inc over the last 50 days is at 39.67%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 42.53%. Further, the company’s Stochastic %K and %D values for the last 20 days were 59.86% and 60.24%, respectively.
CLRB Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 34.30% this year. Over the last six months, there has been a weaker performance of 33.81%. The price of CLRB leaped by -8.15% during the last 30 days period. For the last 5-days stocks have improved 2.34%.
